Silvestris N - Search Results

1

Extensive small cell lung cancer: standard and experimental treatment approaches in elderly patients.

Silvestris N, Lorusso V. Silvestris N, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii64-66. doi: 10.1093/annonc/mdj927. Ann Oncol. 2006. PMID: 16608988 Free article. Review. No abstract available.

2

Silvestris N, Crucitta E, Lorusso V, Gamucci T, De Lena M. Silvestris N, et al. Int J Oncol. 2002 Mar;20(3):611-5. Int J Oncol. 2002. PMID: 11836577 Review.

3

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review).

Crucitta E, Fornier MN, Locopo N, Silvestris N, Lorusso V, De Lena M. Crucitta E, et al. Among authors: silvestris n. Int J Oncol. 2002 Jun;20(6):1283-8. Int J Oncol. 2002. PMID: 12012011 Review.

4

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

Lorusso V, Crucitta E, Panza N, Silvestris N, Guida M, Carpagnano F, Mancarella S, Sambiasi D, De Lena M. Lorusso V, et al. Among authors: silvestris n. Ann Oncol. 2002 Dec;13(12):1862-7. doi: 10.1093/annonc/mdf308. Ann Oncol. 2002. PMID: 12453853 Free article. Clinical Trial.

5

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.

Lorusso V, Crucitta E, Silvestris N, Catino A, Caporusso L, Mazzei A, Guida M, Latorre A, Sambiasi D, D'Amico C, Schittulli F, Calabrese P, De Lena M. Lorusso V, et al. Among authors: silvestris n. Br J Cancer. 2003 Feb 24;88(4):491-5. doi: 10.1038/sj.bjc.6600780. Br J Cancer. 2003. PMID: 12592360 Free PMC article. Clinical Trial.

6

The role of letrozole (Femara(R)) in breast cancer therapy: A clinical review.

Crucitta E, Locopo N, Silvestris N, De Lena M, Lorusso V. Crucitta E, et al. Among authors: silvestris n. Drugs Today (Barc). 2001 Sep;37(9):639-644. doi: 10.1358/dot.2001.37.9.662780. Drugs Today (Barc). 2001. PMID: 12743635

7

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

Lorusso V, Crucitta E, Silvestris N, Guida M, Misino A, Latorre A, De Lena M. Lorusso V, et al. Among authors: silvestris n. Clin Breast Cancer. 2003 Jun;4(2):138-41. doi: 10.3816/cbc.2003.n.019. Clin Breast Cancer. 2003. PMID: 12864942 Clinical Trial.

8

Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report.

Silvestris N, Piscitelli D, Crucitta E, Fiore M, De Lena M, Lorusso V. Silvestris N, et al. J Chemother. 2003 Oct;15(5):507-9. doi: 10.1179/joc.2003.15.5.507. J Chemother. 2003. PMID: 14603882

9

Rationale for the use of gemcitabine in breast cancer (Review).

Silvestris N, D'Aprile M, Andreola G, Locopo N, Marini L, Crucitta E, De Lena M, Lorusso V. Silvestris N, et al. Int J Oncol. 2004 Feb;24(2):389-98. doi: 10.3892/ijo.24.2.389. Int J Oncol. 2004. PMID: 14719116 Review.

10

Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.

Lorusso V, Crucitta E, Silvestris N, Rosati G, Manzione L, De Lena M, Palmeri S, Gebbia V, Mancarella S, Sobrero A, Pezzella G, Comella P, Mangiameli A, Muci D; Italian Bladder Cancer Group. Lorusso V, et al. Among authors: silvestris n. Oncol Rep. 2005 Feb;13(2):283-7. Oncol Rep. 2005. PMID: 15643512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters